← Back to Search

Probiotic

Experimental: Limosilactobacillus Supplement for Urinary Tract Infection

N/A

Recruiting

Research Sponsored by Church & Dwight Company, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial will see if Limosilactobacillus reuteri 3613 can prevent or reduce UTIs in women w/ a history of recurrent UTIs vs. a placebo.

Eligible Conditions

Urinary Tract Infection

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence rate of symptomatic UTI

Proportion of subjects experiencing ≥1 symptomatic UTI

Secondary outcome measures

Proportion of subjects experiencing different numbers of UTI

Quality of Life change

Time for the first UTI

+3 more

Other outcome measures

Safety assessment

Time for vaginal presence of the probiotic

Tolerability

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Experimental: Limosilactobacillus SupplementExperimental Treatment1 Intervention

Capsules containing Probiotic taken daily for 6 month

Group II: PlaceboPlacebo Group1 Intervention

Capsules containing Microcrystalline cellulose, magnesium stearate taken Daily for 6 month

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Church & Dwight Company, Inc.Lead Sponsor

26 Previous Clinical Trials

3,476 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment still open for this experimental research project?

"According to the source material on clinicaltrials.gov, this experiment is still recruiting members and was first established on May 7th 2021. The information was recently updated on March 20th of this year."

Answered by AI

Would individuals who are younger than 75 years old be considered acceptable candidates for this experiment?

"Per the specified inclusion criteria, individuals between 18 and 65 are eligible for this clinical trial. However, 358 studies cater to minors while 1492 trials target elderly patients."

Answered by AI

Who has access to the opportunity of joining this medical experiment?

"Prospective participants should meet the age requirements of 18-65 and display symptoms of urinary tract infection to be eligible for this trial. This research is recruiting a total of 130 individuals."

Answered by AI

What is the primary intent behind this clinical investigation?

"The primary measure of efficacy over a 6-month period will be the proportion of participants who experience at least one symptomatic urinary tract infection (UTI). Additionally, secondary outcomes include the proportions and total number of UTIs experienced across product groups from V2 to Final V5, as well as any differences between probiotic treatment and placebo in terms of time for first UTI occurrence within this same timeframe."

Answered by AI

How many participants have been enlisted for this clinical investigation?

"Yes, according to the information provided by clinicaltrials.gov, this medical trial is still recruiting patients. It was initially posted on May 7th 2021 and updated most recently on March 20th 2023, with a target of 130 participants from one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assess the Effects of a Limosilactobacillus Supplement on Recurrence of UTI in Healthy Women During a 6-month Period

2021. "Assess the Effects of a Limosilactobacillus Supplement on Recurrence of UTI in Healthy Women During a 6-month Period". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05793814.